19 June 2013
Keywords: cordis, new, stent, approved, use, europe, usa
Article | 03 July 2006
The USA's Cordis Corp, a world-leader in the drug-eluting stent market, says that its Cypher Select Plus has become the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 July 2006
18 June 2013
© 2013 thepharmaletter.com